PortfoliosLab logoPortfoliosLab logo
HIVE vs. SOL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HIVE vs. SOL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HIVE Blockchain Technologies Ltd (HIVE) and ReneSola Ltd (SOL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


HIVE

1D
-3.52%
1M
68.46%
YTD
69.77%
6M
33.54%
1Y
132.98%
3Y*
10.46%
5Y*
-18.86%
10Y*

SOL

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HIVE vs. SOL - Yearly Performance Comparison


Fundamentals

EPS

HIVE:

-$0.33

SOL:

-$0.10

PS Ratio

HIVE:

3.75

SOL:

1.40

Total Revenue (TTM)

HIVE:

$257.14M

SOL:

$71.23M

Gross Profit (TTM)

HIVE:

$58.57M

SOL:

$24.18M

EBITDA (TTM)

HIVE:

$87.81M

SOL:

-$20.64M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HIVE vs. SOL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIVE
HIVE Risk / Return Rank: 7474
Overall Rank
HIVE Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
HIVE Sortino Ratio Rank: 8080
Sortino Ratio Rank
HIVE Omega Ratio Rank: 7575
Omega Ratio Rank
HIVE Calmar Ratio Rank: 7272
Calmar Ratio Rank
HIVE Martin Ratio Rank: 6565
Martin Ratio Rank

SOL
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIVE vs. SOL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HIVE Blockchain Technologies Ltd (HIVE) and ReneSola Ltd (SOL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HIVESOLDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.27

Calmar ratioReturn relative to maximum drawdown

1.79

Martin ratioReturn relative to average drawdown

2.89

HIVE vs. SOL - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


HIVESOLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.11

Drawdowns

HIVE vs. SOL - Drawdown Comparison

The maximum HIVE drawdown since its inception was -97.73%, which is greater than SOL's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HIVE and SOL.


Loading charts...

Drawdown Indicators


HIVESOLDifference

Max Drawdown

Largest peak-to-trough decline

-97.73%

0.00%

-97.73%

Max Drawdown (1Y)

Largest decline over 1 year

-74.86%

Max Drawdown (3Y)

Largest decline over 3 years

-80.27%

Max Drawdown (5Y)

Largest decline over 5 years

-94.61%

Current Drawdown

Current decline from peak

-83.67%

0.00%

-83.67%

Average Drawdown

Average peak-to-trough decline

-78.58%

0.00%

-78.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.13%

Volatility

HIVE vs. SOL - Volatility Comparison


Loading charts...

Volatility by Period


HIVESOLDifference

Volatility (1M)

Calculated over the trailing 1-month period

35.94%

Volatility (6M)

Calculated over the trailing 6-month period

64.68%

Volatility (1Y)

Calculated over the trailing 1-year period

94.75%

0.00%

+94.75%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.84%

0.00%

+92.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

109.18%

0.00%

+109.18%

Dividends

HIVE vs. SOL - Dividend Comparison

Neither HIVE nor SOL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HIVE vs. SOL - Financials Comparison

This section allows you to compare key financial metrics between HIVE Blockchain Technologies Ltd and ReneSola Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
93.11M
15.64M
(HIVE) Total Revenue
(SOL) Total Revenue
Values in USD except per share items

HIVE vs. SOL - Profitability Comparison

The chart below illustrates the profitability comparison between HIVE Blockchain Technologies Ltd and ReneSola Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
34.5%
60.8%
Portfolio components
HIVE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HIVE Blockchain Technologies Ltd reported a gross profit of 32.14M and revenue of 93.11M. Therefore, the gross margin over that period was 34.5%.

SOL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ReneSola Ltd reported a gross profit of 9.52M and revenue of 15.64M. Therefore, the gross margin over that period was 60.8%.

HIVE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HIVE Blockchain Technologies Ltd reported an operating income of 16.70M and revenue of 93.11M, resulting in an operating margin of 17.9%.

SOL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ReneSola Ltd reported an operating income of 6.82M and revenue of 15.64M, resulting in an operating margin of 43.6%.

HIVE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HIVE Blockchain Technologies Ltd reported a net income of -91.33M and revenue of 93.11M, resulting in a net margin of -98.1%.

SOL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ReneSola Ltd reported a net income of 3.47M and revenue of 15.64M, resulting in a net margin of 22.2%.


Portfolio Optimizer

Find the right allocation for HIVE and SOL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer